X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs LUPIN LTD - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA LUPIN LTD ABBOTT INDIA/
LUPIN LTD
 
P/E (TTM) x 44.2 20.0 221.1% View Chart
P/BV x 11.0 2.7 407.5% View Chart
Dividend Yield % 0.6 0.9 65.7%  

Financials

 ABBOTT INDIA   LUPIN LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
LUPIN LTD
Mar-17
ABBOTT INDIA/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs6,0151,750 343.7%   
Low Rs3,7071,384 267.9%   
Sales per share (Unadj.) Rs1,236.9387.4 319.3%  
Earnings per share (Unadj.) Rs122.256.6 215.7%  
Cash flow per share (Unadj.) Rs129.076.8 167.9%  
Dividends per share (Unadj.) Rs35.007.50 466.7%  
Dividend yield (eoy) %0.70.5 150.4%  
Book value per share (Unadj.) Rs521.2298.9 174.4%  
Shares outstanding (eoy) m21.25451.58 4.7%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x3.94.0 97.2%   
Avg P/E ratio x39.827.7 143.8%  
P/CF ratio (eoy) x37.720.4 184.8%  
Price / Book Value ratio x9.35.2 177.9%  
Dividend payout %28.613.2 216.3%   
Avg Mkt Cap Rs m103,296707,513 14.6%   
No. of employees `0003.016.8 17.6%   
Total wages/salary Rs m3,37028,495 11.8%   
Avg. sales/employee Rs Th8,891.810,418.3 85.3%   
Avg. wages/employee Rs Th1,140.01,697.0 67.2%   
Avg. net profit/employee Rs Th878.31,523.0 57.7%   
INCOME DATA
Net Sales Rs m26,284174,943 15.0%  
Other income Rs m5041,065 47.4%   
Total revenues Rs m26,789176,008 15.2%   
Gross profit Rs m3,66544,931 8.2%  
Depreciation Rs m1449,122 1.6%   
Interest Rs m81,525 0.5%   
Profit before tax Rs m4,01735,349 11.4%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4219,785 14.5%   
Profit after tax Rs m2,59625,575 10.2%  
Gross profit margin %13.925.7 54.3%  
Effective tax rate %35.427.7 127.8%   
Net profit margin %9.914.6 67.6%  
BALANCE SHEET DATA
Current assets Rs m14,446119,542 12.1%   
Current liabilities Rs m4,72561,206 7.7%   
Net working cap to sales %37.033.3 110.9%  
Current ratio x3.12.0 156.5%  
Inventory Days Days5176 67.6%  
Debtors Days Days2090 21.8%  
Net fixed assets Rs m1,113131,660 0.8%   
Share capital Rs m213903 23.5%   
"Free" reserves Rs m10,808134,073 8.1%   
Net worth Rs m11,076134,976 8.2%   
Long term debt Rs m056,478 0.0%   
Total assets Rs m16,241266,073 6.1%  
Interest coverage x497.024.2 2,055.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.60.7 246.1%   
Return on assets %16.010.2 157.4%  
Return on equity %23.418.9 123.7%  
Return on capital %36.319.3 188.6%  
Exports to sales %0.60-   
Imports to sales %12.60-   
Exports (fob) Rs m162NA-   
Imports (cif) Rs m3,322NA-   
Fx inflow Rs m26881,885 0.3%   
Fx outflow Rs m3,92721,506 18.3%   
Net fx Rs m-3,65960,378 -6.1%   
CASH FLOW
From Operations Rs m2,51441,148 6.1%  
From Investments Rs m-800-25,287 3.2%  
From Financial Activity Rs m-8034,332 -18.5%  
Net Cashflow Rs m91220,193 4.5%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 75.0 0.2 37,500.0%  
Indian inst/Mut Fund % 7.9 11.3 69.9%  
FIIs % 0.1 31.9 0.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.1 169.3%  
Shareholders   18,270 98,259 18.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  ELDER PHARMA  ALEMBIC LTD  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Continues Momentum; Metal Sector Up 2.5%(11:30 am)

After opening the day on a positive note, stock markets in India have continued their momentum. Sectoral indices are trading on a positive note with stocks in the metal sector.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 23, 2018 12:45 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS